Profiling Non-motor Symptoms in Monogenic Parkinson's Disease

Frontiers in Aging Neuroscience
Xinyao Liu, Weidong Le

Abstract

Parkinson's disease (PD) is the second most common neurodegenerative disease in the elder population, pathologically characterized by the progressive loss of dopaminergic neurons in the substantia nigra. While the precise mechanisms underlying the pathogenesis of PD remain unknown, various genetic factors have been proved to be associated with PD. To date, at least 23 loci and 19 disease-causing genes for PD have been identified. Although monogenic (often familial) cases account for less than 5% of all PD patients, exploring the phenotypes of monogenic PD can help us understand the disease pathogenesis and progression. Primary motor symptoms are important for PD diagnosis but only detectable at a relatively late stage. Despite typical motor symptoms, various non-motor symptoms (NMS) including sensory complaints, mental disorders, autonomic dysfunction, and sleep disturbances also have negative impacts on the quality of life in PD patients and pose major challenges for disease management. NMS is common in all stages of the PD course. NMS can occur long before the onset of PD motor symptoms or can present in the middle or late stage of the disease accompanied by motor symptoms. Therefore, the profiling and characterization of NMS...Continue Reading

References

May 24, 2003·Brain : a Journal of Neurology·Naheed L KhanNiall Quinn
Nov 1, 2003·Science·A B SingletonK Gwinn-Hardy
Jan 23, 2004·Brain : a Journal of Neurology·Amanda SingletonDavid S Goldstein
Feb 3, 2004·Annals of Neurology·Matt FarrerJ William Langston
Apr 17, 2004·Science·Enza Maria ValenteNicholas W Wood
Sep 7, 2004·Annals of Neurology·Enza Maria ValenteAnna Rita Bentivoglio
Sep 25, 2004·Movement Disorders : Official Journal of the Movement Disorder Society·Katja HedrichPatricia Kramer
Sep 30, 2004·Annals of Neurology·Hatice KumruAlex Iranzo
Nov 16, 2004·Neuron·Coro Paisán-RuízAndrew B Singleton
Apr 27, 2005·Annals of Neurology·Jan O AaslyMatthew Farrer
Jul 13, 2005·Neurology·V BonifatiUNKNOWN Italian Parkinson Genetics Network
Mar 21, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Kallol Ray ChaudhuriCharles W Olanow
Apr 20, 2006·Movement Disorders : Official Journal of the Movement Disorder Society·Hiroyuki TomiyamaNobutaka Hattori
Jan 5, 2007·Journal of Neurology, Neurosurgery, and Psychiatry·Susanne SteinlechnerRebekka Lencer
Jan 30, 2007·Movement Disorders : Official Journal of the Movement Disorder Society·Lilach EphratySharon Hassin-Baer
May 1, 2008·Experimental Cell Research·Narae ShinWongi Seol
Jun 10, 2008·Lancet Neurology·Daniel G HealyUNKNOWN International LRRK2 Consortium
Jun 12, 2008·Movement Disorders : Official Journal of the Movement Disorder Society·Manabu FunayamaNobutaka Hattori
Aug 23, 2008·Parkinsonism & Related Disorders·Ebba LohmannUNKNOWN French Parkinson's Disease Genetics Study Group
Dec 20, 2008·Lancet·Gregory A Grabowski
Mar 17, 2009·Brain : a Journal of Neurology·Juliane NeumannNicholas W Wood
Aug 13, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Nadège LimousinIsabelle Arnulf
Oct 23, 2009·The New England Journal of Medicine·E SidranskyS G Ziegler
Nov 6, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Alessandro FerrarisAnna Rita Bentivoglio
Feb 24, 2010·Journal of Inherited Metabolic Disease·Gilberto BultronPramod K Mistry
Feb 23, 2011·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·C-L HuangC-S Lu
May 3, 2011·Nature Reviews. Drug Discovery·Wassilios G MeissnerErwan Bezard
Jun 7, 2011·Parkinsonism & Related Disorders·Krisztina K JohansenJan O Aasly
Jul 8, 2011·Neurology·K BrockmannD Berg
Jul 19, 2011·American Journal of Human Genetics·Carles Vilariño-GüellMatthew J Farrer
Nov 8, 2011·Parkinsonism & Related Disorders·Samia Ben SassiFayçal Hentati
Dec 16, 2011·Human Molecular Genetics·Mark W DodsonMing Guo
Aug 29, 2012·Movement Disorders : Official Journal of the Movement Disorder Society·Etienne C HirschSerge Przedborski
Sep 8, 2012·Movement Disorders : Official Journal of the Movement Disorder Society·Laura L KilarskiHuw R Morris
Sep 20, 2012·Movement Disorders : Official Journal of the Movement Disorder Society·Maya AndoNobutaka Hattori
Nov 6, 2012·Cold Spring Harbor Perspectives in Biology·Derek NarendraRichard Youle

❮ Previous
Next ❯

Methods Mentioned

BETA
GTPase
genotyping

Software Mentioned

iPD

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology
Ning ZhangYingdong Zhang
The Journal of the Association of Physicians of India
Manmohan MehndirattaSanjay Pandey
Parkinsonism & Related Disorders
Anna SauerbierK Ray Chaudhuri
© 2021 Meta ULC. All rights reserved